Wendy Pang
About Wendy Pang
Senior Vice President at Jasper Therapeutics
Wendy Pang, M.D., Ph.D., serves as the Senior Vice President, Research and Translational Medicine at Jasper Therapeutics. She joined Jasper with the Series A funding and has since been instrumental in leading early research and development. Her efforts include the creation of the company’s mRNA stem cell graft platform and advancing JSP191 across multiple clinical studies.
Educational Background and Fellowships
Wendy Pang holds an MD and PhD in Cancer Biology from Stanford University. Her academic journey includes both master’s and bachelor’s degrees in Biology from Harvard University. She was a Resident and Fellow in hematology at Stanford University School of Medicine and a Walter and Idun Berry Postdoctoral Fellow in the Judith Shizuru laboratory at Stanford.
Research and Clinical Practice
Throughout her career, Wendy Pang has maintained an active clinical practice and conducted translational research in hematology/oncology and stem cell biology. Previously, she was an Instructor in the Division of Blood and Marrow Transplantation at Stanford University, where she played a key role in numerous studies and authored several publications on hematopoietic stem and progenitor cell behavior.
Publication and Patent Contributions
Wendy Pang has authored numerous publications focusing on the identification and characterization of hematopoietic stem and progenitor cell behavior in aging, non-malignant hematopoietic diseases, and hematopoietic malignancies like MDS and AML. Additionally, she holds multiple patents and patent applications, underscoring her contributions to the field.
Key Research Initiatives
Wendy Pang was the lead author on proof-of-concept studies that demonstrated an anti-CD117 antibody therapy targeting disease-initiating human hematopoietic stem cells in myelodysplastic syndrome (MDS). Her early research initiatives significantly contributed to the advancement of treatments in the sector. She was also a National Institutes of Health Regenerative Medicine Predoctoral Fellow in the Irving Weissman laboratory at Stanford.